• Publications
  • Influence
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer's disease
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) has developed brief, comprehensive, and reliable batteries of clinical and neuropsychological tests for assessment of patientsExpand
  • 2,933
  • 176
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
The Neuropathology Task Force of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) has developed a practical and standardized neuropathology protocol for the postmortemExpand
  • 3,320
  • 156
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery
The neuropsychological tests developed for the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) are currently used to measure cognitive impairments of Alzheimer's disease (AD) inExpand
  • 976
  • 46
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
Although familial factors in Alzheimer's disease (AD) are well established, uniform family-history assessment in genetic and epidemiologic studies of AD is needed to reconcile the divergent estimatesExpand
  • 376
  • 30
Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures.
The present study was designed to determine which of the memory tasks included in the CERAD (Consortium to Establish a Registry for Alzheimer's Disease) neuropsychological battery best differentiateExpand
  • 589
  • 17
Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease
We studied the frequency, severity, and clinical correlations of cerebral amyloid angiopathy (CAA) in 117 CERAD subjects with autopsy-confirmed AD. Eighty-three percent showed at least a mild degreeExpand
  • 435
  • 17
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
Although extrapyramidal signs such as rigidity, bradykinesia, and postural impairment frequently occur in patients with Alzheimer's disease (AD), the correlation of these parkinsonian manifestationsExpand
  • 298
  • 17
Consortium to Establish a Registry for Alzheimer’s Disease (CERAD): The first twenty years
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) was funded by the National Institute on Aging in 1986 to develop standardized, validated measures for the assessment ofExpand
  • 197
  • 16
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part XIV
We made follow-up observations on 1,036 Consortium to Establish a Registry for Alzheimer's Disease (CERAD) patients with Alzheimer's disease (AD) enrolled in 21 university medical centers in theExpand
  • 156
  • 12